NVP-BSK805 dihydrochloride is primarily used in research settings to study and inhibit JAK2 signaling pathways. It is a potent and selective JAK2 inhibitor, making it valuable for investigating the role of JAK2 in various cellular processes and diseases, particularly myeloproliferative disorders. Researchers utilize this compound to explore its potential therapeutic effects in conditions like polycythemia vera, essential thrombocythemia, and myelofibrosis. Additionally, it serves as a tool to understand the mechanisms of JAK-STAT signaling and its implications in cancer biology and immune responses. Its application extends to preclinical studies aimed at developing targeted therapies for JAK2-driven diseases.